vs
Ouster, Inc.（OUST）与ARS Pharmaceuticals, Inc.（SPRY）财务数据对比。点击上方公司名可切换其他公司
Ouster, Inc.的季度营收约是ARS Pharmaceuticals, Inc.的1.7倍（$48.6M vs $28.1M），Ouster, Inc.净利率更高（8.2% vs -147.1%，领先155.3%），Ouster, Inc.同比增速更快（48.9% vs -67.6%）
Ouster, Inc.是总部位于美国加利福尼亚州旧金山的激光雷达技术企业，主打高分辨率数字化3D激光雷达传感器，产品广泛应用于自动驾驶车辆、工业自动化、机器人、无人机、地图测绘、国防及安防等领域。
ARS Pharmaceuticals是一家处于后期研发阶段的生物制药企业，专注于开发和商业化严重过敏反应创新疗法，核心产品为无需注射的肾上腺素鼻腔递送制剂，主要面向北美市场，服务存在致命过敏风险的成人及儿童患者群体。
OUST vs SPRY — 直观对比
营收规模更大
OUST
是对方的1.7倍
$28.1M
营收增速更快
OUST
高出116.4%
-67.6%
净利率更高
OUST
高出155.3%
-147.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $48.6M | $28.1M |
| 净利润 | $4.0M | $-41.3M |
| 毛利率 | 42.9% | — |
| 营业利润率 | 17.6% | -147.6% |
| 净利率 | 8.2% | -147.1% |
| 营收同比 | 48.9% | -67.6% |
| 净利润同比 | — | -182.8% |
| 每股收益（稀释后） | $0.06 | $-0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OUSTSPRY
| Q1 26 | $48.6M | — | ||
| Q4 25 | $62.2M | $28.1M | ||
| Q3 25 | $39.5M | $32.5M | ||
| Q2 25 | $35.0M | $15.7M | ||
| Q1 25 | $32.6M | $8.0M | ||
| Q4 24 | $30.1M | $86.6M | ||
| Q3 24 | $28.1M | $2.1M | ||
| Q2 24 | $27.0M | $500.0K |
净利润OUSTSPRY
| Q1 26 | $4.0M | — | ||
| Q4 25 | — | $-41.3M | ||
| Q3 25 | $-21.7M | $-51.2M | ||
| Q2 25 | $-20.6M | $-44.9M | ||
| Q1 25 | $-22.0M | $-33.9M | ||
| Q4 24 | — | $49.9M | ||
| Q3 24 | $-25.6M | $-19.1M | ||
| Q2 24 | $-23.9M | $-12.5M |
毛利率OUSTSPRY
| Q1 26 | 42.9% | — | ||
| Q4 25 | 60.2% | — | ||
| Q3 25 | 42.1% | — | ||
| Q2 25 | 45.2% | — | ||
| Q1 25 | 41.3% | — | ||
| Q4 24 | 43.8% | — | ||
| Q3 24 | 38.3% | — | ||
| Q2 24 | 33.7% | — |
营业利润率OUSTSPRY
| Q1 26 | 17.6% | — | ||
| Q4 25 | 1.5% | -147.6% | ||
| Q3 25 | -61.4% | -163.7% | ||
| Q2 25 | -76.5% | -302.9% | ||
| Q1 25 | -73.0% | -466.3% | ||
| Q4 24 | -85.1% | 54.5% | ||
| Q3 24 | -98.0% | -1051.6% | ||
| Q2 24 | -93.6% | -3068.0% |
净利率OUSTSPRY
| Q1 26 | 8.2% | — | ||
| Q4 25 | — | -147.1% | ||
| Q3 25 | -55.0% | -157.4% | ||
| Q2 25 | -58.8% | -285.6% | ||
| Q1 25 | -67.5% | -425.7% | ||
| Q4 24 | — | 57.7% | ||
| Q3 24 | -91.1% | -925.0% | ||
| Q2 24 | -88.4% | -2503.2% |
每股收益（稀释后）OUSTSPRY
| Q1 26 | $0.06 | — | ||
| Q4 25 | $0.10 | $-0.41 | ||
| Q3 25 | $-0.37 | $-0.52 | ||
| Q2 25 | $-0.38 | $-0.46 | ||
| Q1 25 | $-0.42 | $-0.35 | ||
| Q4 24 | $-0.46 | $0.52 | ||
| Q3 24 | $-0.54 | $-0.20 | ||
| Q2 24 | $-0.53 | $-0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $173.1M | $245.0M |
| 总债务越低越好 | — | $96.4M |
| 股东权益账面价值 | $275.6M | $114.3M |
| 总资产 | $381.5M | $327.7M |
| 负债/权益比越低杠杆越低 | — | 0.84× |
8季度趋势，按日历期对齐
现金及短期投资OUSTSPRY
| Q1 26 | $173.1M | — | ||
| Q4 25 | $208.6M | $245.0M | ||
| Q3 25 | $244.5M | $288.2M | ||
| Q2 25 | $226.5M | $240.1M | ||
| Q1 25 | $168.2M | $275.7M | ||
| Q4 24 | $172.0M | $314.0M | ||
| Q3 24 | $151.4M | $204.6M | ||
| Q2 24 | $184.2M | $218.7M |
总债务OUSTSPRY
| Q1 26 | — | — | ||
| Q4 25 | — | $96.4M | ||
| Q3 25 | — | $96.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益OUSTSPRY
| Q1 26 | $275.6M | — | ||
| Q4 25 | $261.7M | $114.3M | ||
| Q3 25 | $247.4M | $147.7M | ||
| Q2 25 | $221.0M | $192.3M | ||
| Q1 25 | $167.9M | $229.0M | ||
| Q4 24 | $180.9M | $256.8M | ||
| Q3 24 | $171.7M | $201.0M | ||
| Q2 24 | $170.6M | $215.2M |
总资产OUSTSPRY
| Q1 26 | $381.5M | — | ||
| Q4 25 | $349.5M | $327.7M | ||
| Q3 25 | $353.8M | $372.8M | ||
| Q2 25 | $321.8M | $313.5M | ||
| Q1 25 | $268.6M | $327.3M | ||
| Q4 24 | $276.1M | $351.2M | ||
| Q3 24 | $255.2M | $217.6M | ||
| Q2 24 | $309.9M | $222.0M |
负债/权益比OUSTSPRY
| Q1 26 | — | — | ||
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-43.5M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流OUSTSPRY
| Q1 26 | — | — | ||
| Q4 25 | $-15.4M | $-43.5M | ||
| Q3 25 | $-18.3M | $-47.0M | ||
| Q2 25 | $-1.3M | $-39.6M | ||
| Q1 25 | $-4.9M | $-40.7M | ||
| Q4 24 | $-2.6M | $42.0M | ||
| Q3 24 | $-3.8M | $-14.5M | ||
| Q2 24 | $-21.6M | $-7.3M |
自由现金流OUSTSPRY
| Q1 26 | — | — | ||
| Q4 25 | $-37.2M | — | ||
| Q3 25 | $-20.0M | $-47.2M | ||
| Q2 25 | $-2.2M | $-39.6M | ||
| Q1 25 | $-5.4M | $-40.8M | ||
| Q4 24 | $-4.0M | $41.7M | ||
| Q3 24 | $-4.3M | $-14.6M | ||
| Q2 24 | $-22.0M | $-7.3M |
自由现金流率OUSTSPRY
| Q1 26 | — | — | ||
| Q4 25 | -59.8% | — | ||
| Q3 25 | -50.7% | -145.4% | ||
| Q2 25 | -6.3% | -252.2% | ||
| Q1 25 | -16.6% | -512.1% | ||
| Q4 24 | -13.3% | 48.2% | ||
| Q3 24 | -15.4% | -706.3% | ||
| Q2 24 | -81.5% | -1463.4% |
资本支出强度OUSTSPRY
| Q1 26 | — | — | ||
| Q4 25 | 35.0% | 0.0% | ||
| Q3 25 | 4.3% | 0.6% | ||
| Q2 25 | 2.5% | 0.3% | ||
| Q1 25 | 1.7% | 1.1% | ||
| Q4 24 | 4.8% | 0.3% | ||
| Q3 24 | 2.0% | 6.8% | ||
| Q2 24 | 1.3% | 7.6% |
现金转化率OUSTSPRY
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.84× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OUST
| Product revenue | $48.2M | 99% |
| Royalties | $347.0K | 1% |
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
